首页> 外文期刊>Annals of Clinical Microbiology and Antimicrobials >Association of prenatal antibiotics with measures of infant adiposity and the gut microbiome
【24h】

Association of prenatal antibiotics with measures of infant adiposity and the gut microbiome

机译:产前抗生素与婴儿肥胖和肠道微生物组指标的关联

获取原文
       

摘要

Prenatal antibiotic exposure has been associated with an?altered infant gut?microbiome composition?and higher risk of?childhood obesity, but no studies have examined if prenatal antibiotics simultaneously?alter the gut?microbiome and adiposity in infants. In this prospective study (Nurture: recruitment 2013–2015 in North Carolina, United States), we examined in 454 infants the association of prenatal antibiotic exposure (by any prenatal antibiotic exposure; by trimester of pregnancy; by number of courses; by type of antibiotics) with infant age- and sex-specific weight-for-length z score (WFL-z) and skinfold thicknesses (subscapular, triceps, abdominal) at 12?months of age. In a subsample, we also examined whether prenatal antibiotic exposure was associated with alterations in the infant gut?microbiome at ages 3 and 12?months. Compared to infants not exposed?to prenatal antibiotics, infants who were exposed to any prenatal antibiotics had 0.21 (95% confidence interval [CI] 0.02, 0.41) higher WFL-z at 12?months, and 0.28 (95% CI 0.02, 0.55) higher WFL-z if they were exposed to antibiotics in the second trimester, after adjustment for potential confounders, birth weight, and gestational age. We also observed a dose-dependent association (P-value for trend?=?0.006) with infants exposed to ≥?3 courses having 0.41 (95% CI 0.13, 0.68) higher WFL-z at 12?months. After further adjustment for delivery method, only second-trimester antibiotic exposure remained associated with higher infant WFL-z (0.27, 95% CI 0.003, 0.54) and subscapular skinfold thickness (0.49?mm, 95% CI 0.11, 0.88) at 12?months. Infants exposed to second-trimester antibiotics versus?not had differential abundance of 13 bacterial amplicon sequence variants (ASVs) at age 3?months and 17 ASVs at 12?months (false discovery rate adjusted P-value ?0.05). Prenatal antibiotic exposure in the second trimester was associated with an?altered infant gut?microbiome composition?at 3 and 12?months and with higher infant WFL-z and subscapular skinfold thickness at 12?months.
机译:产前抗生素暴露与婴儿肠道微生物组的组成改变和儿童肥胖的风险增加有关,但尚无研究检查产前抗生素是否同时改变了婴儿肠道微生物组和肥胖。在这项前瞻性研究(培训:美国北卡罗莱纳州,2013-2015年招募)中,我们检查了454名婴儿的产前抗生素暴露(通过任何产前抗生素暴露,怀孕三个月,疗程数,类型)在12个月大时具有婴儿年龄和性别特定的身高体重比z分数(WFL-z)和皮褶厚度(肩cap下,肱三头肌,腹部)的抗生素)。在一个子样本中,我们还检查了3个月和12个月大时出生前抗生素暴露是否与婴儿肠道微生物组的改变有关。与未接触过产前抗生素的婴儿相比,接触过任何产前抗生素的婴儿在12个月时的WFL-z高0.21(95%置信区间[CI] 0.02,0.41),而0.28(95%CI 0.02,0.55) )在调整了潜在的混杂因素,出生体重和胎龄之后,如果在妊娠中期暴露于抗生素,则WFL-z较高。我们还观察到剂量≥关联(趋势P值= 0.006),≥12个月暴露于≥?3疗程的婴儿的WFL-z高0.41(95%CI 0.13,0.68)。在进一步调整分娩方法后,仅在妊娠中期12岁时与较高的婴儿WFL-z(0.27,95%CI 0.003,0.54)和肩sub下皮褶厚度(0.49?mm,95%CI 0.11,0.88)相关。几个月。暴露于中晚期抗生素的婴儿在3个月大时有13种细菌扩增子序列变异体(ASV)的丰度差异,在12个月大时有17种ASV的差异丰度(错误发现率调整后的P值<0.05)。妊娠中期的产前抗生素暴露与3个月和12个月婴儿肠道肠道微生物组组成改变有关,以及12个月婴儿WFL-z和肩skin下皮褶厚度较高。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号